The Goldilocks Time for Remdesivir - Is Any Indication Just Right?
Date
2021-12-22Journal
New England Journal of MedicinePublisher
Massachusetts Medical SocietyType
Article
Metadata
Show full item recordIdentifier to cite or link to this item
http://hdl.handle.net/10713/17537ae974a485f413a2113503eed53cd6c53
10.1056/NEJMe2118579
Scopus Count
Related articles
- [Remdesivir for patients with severe COVID-19].
- Authors: Augustin M, Hallek M, Nitschmann S
- Issue date: 2020 Jun
- Remdesivir Use in COVID-19 Patients: Cutaneous Adverse Effect or Disease Manifestation?
- Authors: Pulsipher KJ, Presley CL, Szeto MD, Waller JD, Dellavalle RP
- Issue date: 2021 May 1
- Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug?
- Authors: Thalha AMM, Lee YY, Besari A, Omar SFS
- Issue date: 2020 Jun
- Weinreb Amide Approach to the Practical Synthesis of a Key Remdesivir Intermediate.
- Authors: Xie Y, Hu T, Zhang Y, Wei D, Zheng W, Zhu F, Tian G, Aisa HA, Shen J
- Issue date: 2021 Apr 2
- Remdesivir: An Antiviral Still Seeking a Raison d'Être.
- Authors: Cummins NW
- Issue date: 2021 Nov 16